Zoetis Inc. (NYSE:ZTS) continues to mesmerize analysts, making a strong appeal with its bullish performance and positive quarterly dividends. According to Bloomberg.com, nine research firms are currently providing coverage for the stock, all of whom have recommended their followers “buy” Zoetis shares.
These collective recommendations have led to an average consensus rating from the analysts, signaling potential growth opportunities for prospective investors looking for a reliable company in the animal health industry.
Of the eight analysts who have given a buy recommendation, one can conclude that Zoetis is on track to dominate this industry. With a 12-month target price of $221.14 set by those who have issued ratings on the stock in the previous year, there could be tremendous value awaiting investors pursuing long-term investments.
In addition to Zoetis’s commendable stock performance capabilities, it has also recently declared a quarterly dividend where shareholders will receive $0.375 per share. The payout ratio stands at 33.86%, indicating that Zoetis is financially stable while delivering reliable returns to its shareholders. This aspect alone places Zoetis amongst some of the most attractive companies in NYSE and hence should be taken very seriously by investors.
Aside from recommendations made by research and analysis firms, both large-scale and smaller hedge funds have recently made purchases and sales of shares related to Zoetis. Worth Asset Management LLC purchased a new position worth $26,000 earlier this year adding themselves into the vast majority of institutional investors owning 90.23% of the company’s stock while Evermay Wealth Management LLC raised its position by over four times as much as their initial investment – up from 28 to 151 shares – within just one quarter!
Given these impressive statistics coupled with comprehensive analysis and favorable target prices by expert researchers in the field suggests that any individual or organization considering investing in an animal health company would profit greatly from including Zoetis in their portfolio. With its consistently strong performance, and positive returns to shareholders, Zoetis Inc. is a company worth considering for any investor looking to diversify their holdings, as illustrated by the experts themselves!
Zoetis Inc. Receives Positive Ratings and Price Target Increase from Analyst Reports
Zoetis Inc. (NYSE: ZTS) has been set as the primary focus in several research analyst reports. Bank of America has raised the price target on Zoetis from $180.00 to $200.00 and bestowed a “buy” rating to the stock in a recent research note that was executed on Tuesday, April 11th. Similarly, StockNews.com initiated coverage on Zoetis with a “buy” rating for the company in a report that was released on Thursday, May 18th. In addition, Barclays raised their price objective on Zoetis from $250.00 to $260.00 and marked the company with an “overweight” rating in particular research report which surfaced on Tuesday, February 21st.
On Monday, May 8th, Piper Sandler reduced their price objective of Zoetis from $220.00 to $210.00 in another research report.
In related news, an EVP Roxanne Lagano sold 4,338 shares of the company’s stock by means of transaction dated Tuesday, April 18th at an average price of $175.94 per share amounting to a total value of $763,227.72.
An utmost approach has been observed by considering shareholder’s dividends as well; hence, ZTS declared quarterly dividend payable on September 1st Friday which will be paid to shareholders of record as of July 21st Friday Investor’s paid per shareholder will stand at a rate of $0.375 dividend which represents an annualized yield worth approximately 0.89% and amounts as yearly payout ratio stands for around thirty-three percent.
Based on Fintech Focus data analysis retrieved dated August Wednesday opening numbers indicate shares prices marked at $169.14 above market capitalization values valued at over seventy-eight billion dollars approximates five years high historical numbers ZTS is closing this year reaching seven
percent gain given current numbers.
Discussion about this post